Skip to main content
Reimbursement strategy

Market Access Strategy for Medical Devices in Europe

Strategic recommendations on the topic of market access pathways for medical devices and IVD tests

Learn more

White Paper: Evidence requirements for coverage of medical technologies in the Netherlands

Get insights from MTRC White Papers to advance your understanding of five rapid HTA reports from the Netherlands 

Request free of charge
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Ongoing coverage positions by the Dutch Healthcare Institute

The Dutch Healthcare Institute performs health technology assessments to inform decisions about the coverage status of pharmaceutical and non-pharmaceutical medical technologies. Procedures are reviewed according to the criteria of necessity, effectiveness (conformity with “state of science and practice”), cost-effectiveness, and feasibility (later, only in case of review before the implementation of the method). The Ministry of Health, Welfare, and Sport makes a final coverage decision based on the recommendations provided by the ZIN.

As of October 2025, the Dutch Healthcare Institute (ZIN) is working on several coverage positions in the otorhinolaryngology, neurology, dental surgery, cardiovascular, and oncology fields, including the following Med Tech-related topics:

  • Implantation of a second cochlear implant for adults with profound hearing loss or deafness;
  • NightWatch® system for epilepsy;
  • Vertebroplasty for painful vertebral metastases or multiple myeloma sites in the vertebrae;
  • Transcatheter aortic valve implantation (TAVI) in patients with symptomatic severe aortic valve stenosis;
  • Zygomatic implants in patients with a severely resorbed edentulous maxilla.

The full details in Dutch can be found here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Contact us to get a free, three-month, no-obligation trial.